← back to search
Gordon Moody
AstraZeneca (Finland) · FI
Area of research
Oncology · Reproductive Medicine
Research interest
Research interests include CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Ovarian cancer diagnosis and treatment, and Immunotherapy and Immune Responses.
h-index
15
citations
1,745
works
76
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy
Clinical Cancer Research
2014
cited by
47
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Jingwei Qi
· University of California, Los Angeles
1
papers (2014–2014)
Elaina Cajulis
· Amgen (United States)
1
papers (2014–2014)
Gottfried E. Konecny
· UCLA Medical Center
1
papers (2014–2014)
Young-Ah Chung
· Sidney Kimmel Cancer Center
1
papers (2014–2014)
Chi-Ming Li
· Amgen (United States)
1
papers (2014–2014)
Frank J. Calzone
· Instrumental Polymer Technologies (United States)
1
papers (2014–2014)
Guorong Yang
· Chinese PLA General Hospital
1
papers (2014–2014)
Victor E. Velculescu
· Sidney Kimmel Cancer Center
1
papers (2014–2014)
Steven Vonderfecht
· Beckman Research Institute
1
papers (2014–2014)
Dennis J. Slamon
· APLA Health
1
papers (2014–2014)
Pedro J. Beltran
· Cabot (United States)
1
papers (2014–2014)
Brian Belmontes
· Amgen (United States)
1
papers (2014–2014)
Petia Mitchell
· Amgen (United States)
1
papers (2014–2014)